Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyung-Bo Kim

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Oncotarget|June 25, 2017
Correction: Tumor growth suppressive effect of IL-4 through p21-mediated activation of STAT6 in IL-4Rα overexpressed melanoma modelsHye Lim Lee, Mi Hee Park, Ju Kyoung Song, et al.
Chemistry & Biology|June 23, 2007
The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentinPaola Bargagna-Mohan, Adel Hamza, Yang-eon Kim, et al.
Molecular Biosystems|June 23, 2012
Revisiting the role of the immunoproteasome in the activation of the canonical NF-κB pathwayEun Ryoung Jang, Na-Ra Lee, Songhee Han, et al.
Journal of Medicinal Chemistry|July 10, 2014
Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomesGerjan de Bruin, Eva M Huber, Bo-Tao Xin, et al.
Plos One|March 9, 2017
Polymer micelle formulation for the proteasome inhibitor drug carfilzomib: Anticancer efficacy and pharmacokinetic studies in miceJi Eun Park, Se-Eun Chun, Derek Reichel, et al.
Cancer Research|July 12, 2020
Nitrogen Trapping as a Therapeutic Strategy in Tumors with Mitochondrial DysfunctionHanumantha Rao Madala, Iiro Taneli Helenius, Wen Zhou, et al.
Carcinogenesis|August 22, 2012
Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-κB and inhibition of monocyte chemoattractant protein-1 in urethane-induced lung tumor modelNam Jin Lee, Dong Young Choi, Ju Kyoung Song, et al.
Journal of Medicinal Chemistry|February 7, 2015
Proteasome inhibitors with pyrazole scaffolds from structure-based virtual screeningZachary Miller, Keun-Sik Kim, Do-Min Lee, et al.
Nature Medicine|November 28, 2017
cGAS drives noncanonical-inflammasome activation in age-related macular degenerationNagaraj Kerur, Shinichi Fukuda, Daipayan Banerjee, et al.
Science Advances|September 29, 2021
<i>Alu</i> complementary DNA is enriched in atrophic macular degeneration and triggers retinal pigmented epithelium toxicity via cytosolic innate immunityShinichi Fukuda, Siddharth Narendran, Akhil Varshney, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Oncotarget|June 25, 2017
Correction: Tumor growth suppressive effect of IL-4 through p21-mediated activation of STAT6 in IL-4Rα overexpressed melanoma modelsHye Lim Lee, Mi Hee Park, Ju Kyoung Song, et al.
Chemistry & Biology|June 23, 2007
The tumor inhibitor and antiangiogenic agent withaferin A targets the intermediate filament protein vimentinPaola Bargagna-Mohan, Adel Hamza, Yang-eon Kim, et al.
Molecular Biosystems|June 23, 2012
Revisiting the role of the immunoproteasome in the activation of the canonical NF-κB pathwayEun Ryoung Jang, Na-Ra Lee, Songhee Han, et al.
Journal of Medicinal Chemistry|July 10, 2014
Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomesGerjan de Bruin, Eva M Huber, Bo-Tao Xin, et al.
Plos One|March 9, 2017
Polymer micelle formulation for the proteasome inhibitor drug carfilzomib: Anticancer efficacy and pharmacokinetic studies in miceJi Eun Park, Se-Eun Chun, Derek Reichel, et al.
Cancer Research|July 12, 2020
Nitrogen Trapping as a Therapeutic Strategy in Tumors with Mitochondrial DysfunctionHanumantha Rao Madala, Iiro Taneli Helenius, Wen Zhou, et al.
Carcinogenesis|August 22, 2012
Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-κB and inhibition of monocyte chemoattractant protein-1 in urethane-induced lung tumor modelNam Jin Lee, Dong Young Choi, Ju Kyoung Song, et al.
Journal of Medicinal Chemistry|February 7, 2015
Proteasome inhibitors with pyrazole scaffolds from structure-based virtual screeningZachary Miller, Keun-Sik Kim, Do-Min Lee, et al.
Nature Medicine|November 28, 2017
cGAS drives noncanonical-inflammasome activation in age-related macular degenerationNagaraj Kerur, Shinichi Fukuda, Daipayan Banerjee, et al.
Science Advances|September 29, 2021
<i>Alu</i> complementary DNA is enriched in atrophic macular degeneration and triggers retinal pigmented epithelium toxicity via cytosolic innate immunityShinichi Fukuda, Siddharth Narendran, Akhil Varshney, et al.
Pageof 8